Pola Pengobatan Covid-19 pada Pasien Komorbid di RSUD dr. La Palaloi

The Pattern of Treatment for Covid19 in Comorbid Patients at the dr. La Palaloi Hospital

Authors

  • Dwi Fitrah Wahyuni Program Studi DIII Farmasi, Sekolah Tinggi Ilmu Kesehatan Salewangang Maros Author
  • An Nisaa Nurzak Program Studi D-III Farmasi, Stikes Salewangang Maros, Sulawesi Selatan, Indonesia Author
  • Arifuddin Yunus Program Studi D-III Farmasi, Stikes Salewangang Maros, Sulawesi Selatan, Indonesia Author
  • Nabilah Baharuddin Sekolah Tinggi Ilmu Keshatan Salewangang Maros Author https://orcid.org/0000-0002-5499-1853
  • Sitti Nur Intang Program Studi DIII Kebidanan, Sekolah Tinggi Ilmu Kesehatan Salewangang Maros Author

Keywords:

Covid-19 patients, Comorbid Disease

Abstract

As stated by the World Health Organization (WHO) as a global pandemic on March 11, 2020, Coronavirus Disease 2019 (Covid-19), a disease caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), [1]. For suspected and confirmed Covid-19 patients with mild symptoms, the use of antibiotic drugs is not recommended, both for therapy and prevention [2] .After WHO declared Covid-19 a global pandemic, RSUD dr. La Palaloi is one of the hospitals appointed by the government as a referral hospital for handling Covid-19 in Maros district, South Sulawesi. Comorbidity is one of the factors that causes the mortality rate in patients infected with Covid-19 to increase. The purpose of this study was to describe the pattern of prescribing Covid-19 drugs for comorbid patients. The research method used is a retrospective research method to determine the pattern of Covid-19 treatment with comorbid patients at dr. La Palaloi. The most common comorbidity is hypertension. The most antibiotics given to Covid-19 patients were Azithromycin and the most Antibiotics were Oseltamivir. Treatment for the first Covid-19 patient was given antibiotics and antivirals. Treatment for antihypertensives is the CCB group, for the treatment of diabetes is insulin, and for the treatment of bronchopneumonia, antibiotics are given.

References

World Health Organization (WHO). 2020. https://www.who.int/emergencies/diseases/ novelcoronavirus-2019/technical-guidance/naming-thecoronavirus-disease-(covid-2019)-and-the-virus-thatcauses-it . Dipublikasikan 11 Februari 2020. Diakses 23 Maret 2020.

BPOM (2020) Informatorium obat Covid. 2nd edn. jakarta: Badan POM.

Apriyani, D. (2021) ‘Karya Tulis Ilmiah Pola Peresepan Terapi COVID-19 pada Pasien Komorbid Hipertensi di Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita Tahun 2021’, Jurusan Farmasi Poltekkes Kemenkes Jakarta II.

WHO (2021) WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Available at: https://covid19.who.int/ (Accessed: 12 October 2021).

Kementerian Kesehatan Republik Indonesia (2020). Available at: https://www.kemkes.go.id/article/print/20101400002/13-2-persen-pasien-covid-19-yang-meninggal-memiliki-penyakit-hipertensi.html (Accessed: 1 March 2022).

Sulsel Tanggap COVID-19 (2021) Sulsel tanggap covid-19. Available at: https://covid19.sulselprov.go.id/ (Accessed: 13 October 2021).

Karyono, D. R. and Wicaksana, A. L. (2020) ‘Current prevalence , characteristics , and comorbidities of patients with COVID-19 in Indonesia’, 3(August), pp. 77–84. doi: 10.22146/jcoemph.57325.

Guan, W. et al. (2020) ‘Comorbidity and its impact on 1590 patients with COVID-19 in China?: a’, EUOROPEAN RESPIRATORY JOURNAL, (March 2020). doi: 10.1183/13993003.00547-2020.

Jessica Suardi, D. P. (2021) ‘bronko’, Social Clinical Pharmacy Indonesia Journa, 6(1), pp. 1–5.

PDPI et al. (2020) Pedoman tatalaksana COVID-19 Edisi 3 Desember 2020, Pedoman Tatalaksana COVID-19. Available at: https://www.papdi.or.id/ download/983-pedoman-tatalaksana-covid-19-edisi-3-desember-2020.

Yulanda, G. and Lisiswanti, R. (2017) ‘Penatalaksanaan Hipertensi Primer’, Jurnal Majority, 6(1), pp. 25–33.

Medix, O. T. (1962) ‘Steroid?: Meningkatkan Standar Pengobatan COVID-19’.

[Notes,T.M.M. (2019). Basic pharmacology & Drug Notes. MMN Publishing.Makassar.Peraturan Menteri Kesehatan Republik Indonesia Nomor 9 Tahun 2017 tentang Apotik. Departemen Kesehatan RI. Jakarta.

KEMENKES (2020) ‘Mencegah dan Mengontrol Hipertensi Agar Terhindar dari Kerusakan Organ Jantung, Otak dan Ginjal’, Pusat Data dan lnformasi Kementerian Kesehatan Rl.

PERKENI (2021) ‘Pedoman Petunjuk Praktis Terapi Insulin Pada Pasien Diabetes Mellitus 2021’, Pb Perkeni, pp. 32–39.

Hikmawati, I. and Setiyabudi, R. (2020) ‘Hipertensi Dan Diabetes Militus Sebagai Penyakit Penyerta Utama Covid-19 Di Indonesia Hypertension and Diabetes Mellitus As Covid-19 Comorbidities in Indonesia’, Prosiding Seminar Nasional Lppm Ump, 0(0), pp. 95–100. Available at: https://semnaslppm.ump.ac.id/index.php/semnaslppm/article/view/224/219%0Ahttps://semnaslppm.ump.ac.id/index.php/semnaslppm/article/view/224.

Akhsyari FZ. Karakteristik Pasien Diabetes Mellitus di RSUD d. Soehadi Prijonegoro Sragen tahun 2015. 2016;6

Downloads

Published

2022-10-31

Issue

Vol. 4 No. 5 (2022): J. Sains Kes.

Section

Articles

Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/jskff/public_html/plugins/generic/citations/CitationsPlugin.php on line 68

How to Cite

[1]
D. F. Wahyuni, A. N. Nurzak, A. Yunus, N. Baharuddin, and S. N. Intang, “Pola Pengobatan Covid-19 pada Pasien Komorbid di RSUD dr. La Palaloi: The Pattern of Treatment for Covid19 in Comorbid Patients at the dr. La Palaloi Hospital”, J. Sains. Kes, vol. 4, no. 5, pp. 452–458, Oct. 2022, Accessed: Mar. 11, 2026. [Online]. Available: https://jsk.ff.unmul.ac.id/index.php/JSK/article/view/534

Most read articles by the same author(s)

Similar Articles

81-90 of 111

You may also start an advanced similarity search for this article.